/home/corante/public_html/brainwaves/ The field of neurotechnology, the focus of this blog, encompasses advances in brain science (neurons), information technology (bits) and bioengineering (genes). Up for discussion and analysis: the political, economic, ethical, and social forces that will shape the future of what will be one of the most important and fascinating stories of the coming decades. en-us zack@neuroinsights.com 2005-12-01T17:10:23-05:00 hourly 1 2000-01-01T12:00+00:00 http://brainwaves.corante.com/archives/2005/12/01/neurotech_index_reaches_new_highs.php by Casey Lynch NeuroInsights’ Neurotech Index reached new heights in mid November, gaining over 50% since its start in December 2003. As of November 30th, the Neurotech Index, is up 46% compared to respective gains of 12% and 11% for... 39220@/home/corante/public_html/brainwaves/ Casey's Insights 2005-12-01T17:10:23-05:00 http://brainwaves.corante.com/archives/2005/07/28/mind_your_brain_the_neuroscience_of_meditation.php By Casey Lynch, NeuroInsights There is growing interest in the subject of "cognitive fitness". For example, software being developed by companies like Posit may delay Alzheimer’s disease and neurofeedback games like those offered by CyberLearning Technology and Imagine Neuro Solutions... 4478@/home/corante/public_html/brainwaves/ Casey's Insights 2005-07-28T12:00:06-05:00 http://brainwaves.corante.com/archives/2005/07/18/braincells_taps_leading_neurotech_venture_capital.php By Casey Lynch Neuropharmaceutical drug discovery company BrainCells Inc of San Diego announced that it has closed a $17.7 million Series A financing from leading neurotech venture funds including Technology Partners, Oxford Bioscience Partners and NeuroVentures Capital. Recent research from... 4473@/home/corante/public_html/brainwaves/ VC for Neurotech 2005-07-18T17:26:57-05:00 http://brainwaves.corante.com/archives/2005/06/13/micro_therapeutics_gaining_traction_in_neurodevice_market.php by Casey Lynch, NeuroInsights When Tom Wilder left Medtronic to join the neurovascular company Micro Therapeutics he saw a major untapped market opportunity and a floundering company with the potential to execute where bigger companies, like Medtronic, were hesitating. Since... 4452@/home/corante/public_html/brainwaves/ Public Neurotech News 2005-06-13T13:42:03-05:00 http://brainwaves.corante.com/archives/2005/01/12/jp_morgan_sees_booming_insomnia_market.php By Casey Lynch, NeuroInsights The 23rd Annual JP Morgan Healthcare Conference is underway this week in San Francisco where 230 public and 50 private companies are presenting their latest findings to over 6,000 healthcare executives and investors. Of the many... 4356@/home/corante/public_html/brainwaves/ Casey's Insights 2005-01-12T17:43:22-05:00